Skip to main content

PROVINCIAL DRUG COVERAGE – Manitoba

AS OF January 2025

Coverage is under constant review and is subject to change.

Access to a generic or biosimilar equivalent is generally reported to be identical to that of the relevant brand name medication.

TYPE OF LISTING

MANITOBA COVERAGE

Bisphosphonates

Etidronate

Didronel; Generics Available

Not in Drug Formulary

Alendronate

Fosamax; Generics Available

Regular Benefit

Fosavance; Generics Available

Non-Benefit

Risedronate

Actonel; Generics Available

Regular Benefit

Actonel; DR

Non-Benefit

Zoledronic Acid

Aclasta; Generics Available

Limited Coverage

SERMs

Raloxifene

Evista; Generics Available

Limited Coverage

Teriparatide (PTH)

Forteo; Generics Available

Non-Benefit

Osnuvo (biosimilar)

Non-Benefit

Denosumab

Prolia

Limited Coverage

Jubbonti (biosimilar)

Under Expedited Review

Romosozumab

Evenity

Non-Benefit

© Osteoporosis Canada, 2025
Charitable Registration No. 89551 0931 RR 0001